Search Results1-7 of  7

  • TAMAOKI Masashi ID: 9000000880097

    遠軽町役場総務部情報管財課 (2007 from CiNii)

    Articles in CiNii:5

    • An Application of Apatial-Temporal Information System to the Local Government : A Development of Integrated Geographic Database and Common GIS for Sirakawa Town (2001)
    • Development of Spatial Temporal Database including Earthquake Damages and Analysis of Damage Statistics at Nango Town : Spatial Temporal Information System and Construction of Information Environment in Municipality and in Disaster (6) (2004)
    • Developing a Public Hazard Map using Municipal Database : Spatial Temporal Infomation System and Construction of Information Environment in Municipality and in Disaster (7) (2004)
  • Tamaoki Masashi ID: 9000024729965

    Articles in CiNii:1

    • Modulation of Th1/Th2 balance by infliximab rescues postoperative occurrence of small-intestinal inflammation associated with ulcerative colitis. (2010)
  • Tamaoki Masashi ID: 9000326267892

    Articles in CiNii:1

    • Discovery of a good responder subtype of esophageal squamous cell carcinoma with cytotoxic T-lymphocyte signatures activated by chemoradiotherapy (2015)
  • Tamaoki Masashi ID: 9000347362068

    Articles in CiNii:1

    • SIX1 maintains tumor basal cells via transforming growth factor-β pathway and associates with poor prognosis in esophageal cancer (2017)
  • Tamaoki Masashi ID: 9000388539363

    Articles in CiNii:1

    • Multiple roles of single-minded 2 in esophageal squamous cell carcinoma and its clinical implications (2018)
  • Tamaoki Masashi ID: 9000402386783

    Department of Therapeutic Oncology, Kyoto University Graduate School of Medicine (2019 from CiNii)

    Articles in CiNii:1

    • Management for Phototoxicity after Photodynamic Therapy Using Talaporfin Sodium (2019)
  • Tamaoki Masashi ID: 9000402386795

    Department of Clinical Oncology, Kyoto University Hospital (2019 from CiNii)

    Articles in CiNii:1

    • Clinical Outcome of Salvage Photodynamic Therapy Using Talaporfin Sodium for Esophageal Cancer in Our Clinical Practice After Pharmaceutical Approval (2019)
Page Top